High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression: A prospective 4-week naturalistic trial

Journal of Affective Disorders

Volumn 130, Issue 1-2, 2011, Pages 312-317

  Berlim, Marcelo T ^a   McGirr, Alexander ^a   Beaulieu, Marie Martine ^a   Turecki, Gustavo ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Augmentation; Naturalistic studies; Quality of life; Repetitive transcranial magnetic stimulation; Treatment resistant depression

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; GABAPENTIN; LAMOTRIGINE; LITHIUM CARBONATE; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; PRAMIPEXOLE; QUETIAPINE; SERTRALINE; TRANYLCYPROMINE; VENLAFAXINE;

ADULT; ANXIETY; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; DEPRESSION; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; MAJOR DEPRESSION; MALE; PAIN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCALP; SELF REPORT; SYMPTOM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 79953186581     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.10.011     Document Type: Article

References (44)

1. D.H. Avery, P.E. Holtzheimer III, and W. Fawaz A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression Biol. Psychiatry 59 2006 187 194 (Pubitemid 43117509)
2. A.T. Beck, N. Epstein, G. Brown, and R.A. Steer An inventory for measuring clinical anxiety: psychometric properties J. Consult. Clin. Psychol. 56 1988 893 897 (Pubitemid 19008360)
3. M.T. Berlim, and G. Turecki Definition, assessment and staging of treatment resistant/refractory major depression: a review of current concepts and methods Can. J. Psychiatry 51 2006 875 882
4. M.T. Berlim, J. Pargendler, J. Brenner, and M.P. Fleck Significant improvement in the quality of life of Brazilian depressed outpatients 12 weeks following the start of antidepressants Psychiatry Res. 153 2007 253 259 (Pubitemid 47632797)
5. M.T. Berlim, M.P. Fleck, and G. Turecki Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview Ann. Med. 40 2008 149 159 (Pubitemid 351640642)
6. O. Caliyurt, and F. Guducu Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder J. Affect. Disord. 88 2005 75 78 (Pubitemid 41160416)
7. K. Demyttenaere, J.D. Fruyt, and R. Huygens Measuring quality of life in depression Curr. Opin. Psychiatry 15 2003 89 92 (Pubitemid 34081721)
8. K. Demyttenaere, H.F. Andersen, and E.H. Reines Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder Int. Clin. Psychopharmacol. 23 2008 276 286
9. D.L. Dunner, A.J. Rush, and J.M. Russell Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression J. Clin. Psychiatry 67 2006 688 695 (Pubitemid 43946174)
10. K.P. Ebmeier, C. Donaghey, and J.D. Steele Recent developments and current controversies in depression Lancet 367 2006 153 167 (Pubitemid 43077130)
11. M. Fava Diagnosis and definition of treatment-resistant depression Biol. Psychiatry 53 2003 649 659 (Pubitemid 39658481)
12. M.B. First, M. Gibbon, R.L. Spitzer, and J.B.W. Williams Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition with psychotic screen 2001 Biometrics Research, New York State Psychiatric Institute New York
13. P.B. Fitzgerald, T.L. Brown, N.A. Marston, Z.J. Daskalakis, A. De Castella, and J. Kulkarni Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial Arch. Gen. Psychiatry 60 2003 1002 1008 (Pubitemid 37222083)
14. J.C. Fournier, R.J. DeRubeis, and S.D. Hollon Antidepressant drug effects and depression severity: a patient-level meta-analysis JAMA 303 2010 47 53
15. M.S. George, S.H. Lisanby, and D. Avery Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial Arch. Gen. Psychiatry 67 2010 507 516
16. J.F. Greden The burden of disease for treatment-resistant depression J. Clin. Psychiatry 62 Suppl 16 2001 26 31
17. W. Guy ECDEU Assessment Manual for Psychopharmacology 1976 U.S. Department of Health, Education, and Welfare Washington, D.C
18. M. Hamilton The assessment of anxiety states by rating Br. J. Med. Psychol. 32 1959 50 55
19. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
20. M. Hamilton, Hamilton Rating Scale for Depression (Ham-D) 2000 American Psychiatric Publishing Washington, DC
21. L.L. Herrmann, and K.P. Ebmeier Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review J. Clin. Psychiatry 67 2006 1870 1876 (Pubitemid 46048184)
22. U. Herwig, P. Satrapi, and C. Schonfeldt-Lecuona Using the international 10 -20 EEG system for positioning of transcranial magnetic stimulation Brain Topogr. 16 2003 95 99 (Pubitemid 38045059)
23. Horder, J., Matthews, P., Waldmann, R., in press. Placebo, Prozac and PLoS: significant lessons for psychopharmacology, J. Psychopharmacol.
24. S.H. Kennedy, B.S. Eisfeld, and R.G. Cooke Quality of life: an important dimension in assessing the treatment of depression? J. Psychiatry Neurosci. 26 2001 S23 S28 (Suppl)
25. R.W. Lam, P. Chan, M. Wilkins-Ho, and L.N. Yatham Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis Can. J. Psychiatry 53 2008 621 631
26. S.H. Lisanby, M.M. Husain, and P.B. Rosenquist Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial Neuropsychopharmacology 34 2009 522 534
27. A. Mishory, C. Molnar, and J. Koola The maximum-likelihood strategy for determining transcranial magnetic stimulation motor threshold, using parameter estimation by sequential testing is faster than conventional methods with similar precision J. ECT 20 2004 160 165 (Pubitemid 39281566)
28. C.J. Murray, and A.D. Lopez Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study Lancet 349 1997 1436 1442 (Pubitemid 27212192)
29. A.A. Nierenberg, J. Katz, and M. Fava A critical overview of the pharmacologic management of treatment-resistant depression Psychiatr. Clin. North Am. 30 2007 13 29 (Pubitemid 46386307)
30. J.P. O'Reardon, H.B. Solvason, and P.G. Janicak Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Biol. Psychiatry 62 2007 1208 1216 (Pubitemid 350060890)
31. G.I. Papakostas, T. Petersen, Y. Mahal, D. Mischoulon, A.A. Nierenberg, and M. Fava Quality of life assessments in major depressive disorder: a review of the literature Gen. Hosp. Psychiatry 26 2004 13 17 (Pubitemid 38142561)
32. S. Pridmore, J.A. Fernandes Filho, Z. Nahas, C. Liberatos, and M.S. George Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method J. ECT 14 1998 25 27 (Pubitemid 28257252)
33. A.J. Rush, M.E. Thase, and S. Dube Research issues in the study of difficult-to-treat depression Biol. Psychiatry 53 2003 743 753 (Pubitemid 39658488)
34. A.J. Rush, L.B. Marangell, and H.A. Sackeim Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial Biol. Psychiatry 58 2005 347 354 (Pubitemid 41219702)
35. H.A. Sackeim The definition and meaning of treatment-resistant depression J. Clin. Psychiatry 62 Suppl 16 2001 10 17
36. N. Sartorius The economic and social burden of depression J. Clin. Psychiatry 62 Suppl 15 2001 8 11 (Pubitemid 32601342)
37. S.M. Skevington, and A. Wright Changes in the quality of life of patients receiving antidepressant medication in primary care: validation of the WHOQOL-100 Br. J. Psychiatry 178 2001 261 267 (Pubitemid 32183610)
38. S.M. Skevington, M. Lotfy, and K.A. O'Connell The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group Qual. Life Res. 13 2004 299 310 (Pubitemid 38392258)
39. C.W. Slotema, J.D. Blom, H.W. Hoek, and I.E. Sommer Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? a meta-analysis of the efficacy of rTMS in psychiatric disorders J. Clin. Psychiatry 71 7 2010 873 884
40. D. Souery, G.I. Papakostas, and M.H. Trivedi Treatment-resistant depression J. Clin. Psychiatry 67 Suppl 6 2006 16 22 (Pubitemid 44078108)
41. W. Thalheimer, and S. Cook How to calculate effect sizes from published research articles: a simplified methodology Accessed July 24, 2010, at http://work-learning.com/effect-sizes.htm 2002
42. M.E. Thase The need for clinically relevant research on treatment-resistant depression J. Clin. Psychiatry 62 2001 221 224 (Pubitemid 32428758)
43. M.H. Trivedi, A.J. Rush, and H.M. Ibrahim The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation Psychol. Med. 34 2004 73 82 (Pubitemid 38139442)
44. S.B. Woolley, A.A. Cardoni, and J.W. Goethe Last-observation-carried- forward imputation method in clinical efficacy trials: review of 352 antidepressant studies Pharmacotherapy 29 2009 1408 1416